Skip to main content
TipRanks
Go Ultimate75% OFF

Avalo Therapeutics (C6K0) Q3 2021 Earnings Report

0 Followers

DE:C6K0 Q3 2021 EPS Results

Actual EPS
-EUR 444.14
Consensus EPS
-EUR 438.92
Beat/Miss
Missed by -EUR 5.23
One Year Ago EPS
-EUR 418.01

DE:C6K0 Q3 2021 Revenue Results

Actual Revenue
EUR 1.22M
Expected Revenue
EUR 1.01M
Beat/Miss
Beat by +EUR 212.27K
YoY Revenue Growth
+21.53%

Earnings Announcement Details

Quarter
Q3 2021
Date
11/09/2021
Time
After Close
Conference Call
Tuesday, November 9, 2021
DE:C6K0 Upcoming Earnings

Avalo Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q3 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:C6K0 Earnings History

DE:C6K0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)-0.41--0.68――
Nov 05, 20262026 (Q3)-0.53-0.31-1.9984.47% (+1.68)
Aug 06, 20262026 (Q2)-0.53-0.75-1.7456.77% (+0.99)
May 13, 20262026 (Q1)-0.93-0.89-1.1321.60% (+0.24)
Mar 23, 20262025 (Q4)-1.32-0.68-2.0967.39% (+1.41)
Nov 06, 20252025 (Q3)-1.50-1.99-2.5722.61% (+0.58)
Aug 07, 20252025 (Q2)-1.27-1.74-12.7686.35% (+11.02)
May 12, 20252025 (Q1)-1.21-1.13-127.9199.11% (+126.77)
Mar 20, 20252024 (Q4)-0.15-2.09-9.1677.23% (+7.08)
Nov 07, 20242024 (Q3)-1.08-2.57-23.9589.28% (+21.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed